DD216717A5 - Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten - Google Patents

Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten Download PDF

Info

Publication number
DD216717A5
DD216717A5 DD84259963A DD25996384A DD216717A5 DD 216717 A5 DD216717 A5 DD 216717A5 DD 84259963 A DD84259963 A DD 84259963A DD 25996384 A DD25996384 A DD 25996384A DD 216717 A5 DD216717 A5 DD 216717A5
Authority
DD
German Democratic Republic
Prior art keywords
lower alkyl
hydroxy
formula
hydrogen
amino
Prior art date
Application number
DD84259963A
Other languages
German (de)
English (en)
Inventor
Jeffrey W H Watthey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD216717A5 publication Critical patent/DD216717A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD84259963A 1983-02-10 1984-02-09 Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten DD216717A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/465,696 US4470988A (en) 1983-02-10 1983-02-10 Benzazocinone and benzazoninone derivatives, and their pharmaceutical use

Publications (1)

Publication Number Publication Date
DD216717A5 true DD216717A5 (de) 1984-12-19

Family

ID=23848809

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84259963A DD216717A5 (de) 1983-02-10 1984-02-09 Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten

Country Status (20)

Country Link
US (1) US4470988A (da)
EP (1) EP0119161B1 (da)
JP (1) JPS59172474A (da)
KR (1) KR840007872A (da)
AT (1) ATE44279T1 (da)
AU (1) AU2443184A (da)
CA (1) CA1218989A (da)
DD (1) DD216717A5 (da)
DE (1) DE3478810D1 (da)
DK (1) DK58084A (da)
ES (2) ES8606286A1 (da)
FI (1) FI840463A (da)
GR (1) GR81766B (da)
HU (1) HU193671B (da)
IE (1) IE56816B1 (da)
IL (1) IL70882A0 (da)
NO (1) NO840486L (da)
NZ (1) NZ207090A (da)
PT (1) PT78064B (da)
ZA (1) ZA84959B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873235A (en) * 1982-06-01 1989-10-10 Merck & Co., Inc. Benzofused lactams as antihypertensives
US4537885A (en) * 1983-02-10 1985-08-27 Ciba Geigy Corporation Certain benzazocinone and benzazoninone derivatives
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US5145864A (en) * 1987-09-15 1992-09-08 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
RU2124503C1 (ru) 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
ATE206402T1 (de) * 1993-11-22 2001-10-15 Merck & Co Inc 3-acylaminobenzazepine
HU220635B1 (hu) * 1994-08-18 2002-03-28 Merck & Co. Inc. 2,3-Dihidro-1-(2,2,2-trifluor-etil)-2-oxo-5-fenil-1H-1,4-benzodiazepin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
JPH11506760A (ja) * 1995-06-07 1999-06-15 メルク エンド カンパニー インコーポレーテッド 新規なｎ−（２，４−ジオキソ−２，３，４，５−テトラヒドロ−１ｈ−１，５−ベンゾジアゼピン−３イル）−３−アミド
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
EP2544765A1 (en) 2010-03-11 2013-01-16 Merck Patent GmbH Fibers in therapy and cosmetics
WO2023178538A1 (zh) * 2022-03-23 2023-09-28 浙江华海药业股份有限公司 一种纯化左乙拉西坦中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1191963A (en) * 1968-02-07 1970-05-13 Ucb Sa Heterocyclic Compounds
GB1183442A (da) * 1968-02-23 1970-03-04
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel
PT73522B (en) * 1980-08-18 1983-07-14 Merck & Co Inc Process for preparing substituted caprylolactam derivatives as antihypertensives
IL63540A0 (en) * 1980-08-18 1981-11-30 Merck & Co Inc Substituted enantholactam derivatives as antihypertensives
GR74635B (da) * 1980-08-18 1984-06-29 Merck & Co Inc
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents

Also Published As

Publication number Publication date
DE3478810D1 (en) 1989-08-03
IE56816B1 (en) 1991-12-18
KR840007872A (ko) 1984-12-11
AU2443184A (en) 1984-08-16
PT78064B (en) 1986-06-02
ATE44279T1 (de) 1989-07-15
CA1218989A (en) 1987-03-10
FI840463A0 (fi) 1984-02-06
PT78064A (en) 1984-03-01
DK58084D0 (da) 1984-02-09
IE840301L (en) 1984-08-10
IL70882A0 (en) 1984-05-31
HU193671B (en) 1987-11-30
NO840486L (no) 1984-08-13
EP0119161A2 (de) 1984-09-19
EP0119161A3 (en) 1986-06-11
EP0119161B1 (de) 1989-06-28
NZ207090A (en) 1985-10-11
FI840463A (fi) 1984-08-11
JPH0449545B2 (da) 1992-08-11
JPS59172474A (ja) 1984-09-29
ES8606286A1 (es) 1986-04-01
DK58084A (da) 1984-08-11
ZA84959B (en) 1984-09-26
GR81766B (da) 1984-12-12
ES529593A0 (es) 1986-04-01
ES8700240A1 (es) 1986-09-16
US4470988A (en) 1984-09-11
ES544051A0 (es) 1986-09-16

Similar Documents

Publication Publication Date Title
DD216717A5 (de) Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten
EP0119954B1 (de) Gewisse 3-Amino-1-benzazepin-2-on-1-alkansäuren, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
EP0072352B1 (de) Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
EP0150263B1 (de) Derivate der cis, endo-2-Azabicyclo-[3.3.0]-octan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
EP0184550B1 (de) 5-Amino-4-hydroxyvalerylamid-Derivate
EP0111873B1 (de) Derivate der cis, endo-2-Azabicyclo-(5.3.0)-decan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
EP0871653A1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE3210496A1 (de) Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
HU209413B (en) Method for producing 2-azabicyclo [3.1.0] hexane-3-carboxylic acid derivatives as well as their physiologically acceptable salts
DD236522A5 (de) Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen
US4537885A (en) Certain benzazocinone and benzazoninone derivatives
EP0894003A1 (en) N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
DE60014029T2 (de) Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen
WO1992020711A2 (de) Lhrh-antagonisten und zwischenprodukte
EP0203450B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
DD206553A5 (de) Verfahren zur herstellung von tripeptiden
US4066749A (en) Tetrapeptide analog of TRH
EP0115473A2 (de) Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
DE3426720A1 (de) Benzthiazepinon- und benzthiazocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US6777550B1 (en) N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors
EP0236263A2 (de) Substituierte Pyrrolidinone
DE3708484A1 (de) Neue 3-(3-cycloalkylpropyl)amino-1-benzazepin-2-on-1-alkansaeuren
DD263052A5 (de) Verfahren zur herstellung von neuen verbindungen
DD298410A5 (de) Renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln